Healthcare analytics platform
From risk models to a care-management operating system
A 0-to-1 analytics product scaled across nine healthcare programs, connecting risk models, delivery pipelines, dashboards, and care-manager workflows.
- Problem
- Risk models and dashboards were fragmented across programs and disconnected from a repeatable path into care-team action.
- Decision
- Build reusable data and model-delivery services while preserving each program’s population, thresholds, and review workflow.
- Business / proof change
- Scaled across nine programs, supporting $500K in new revenue and approximately $3M in client performance-based payouts.
- Ownership
- Lead data scientist and product partner across modeling, platform delivery, reporting, and workflow adoption
- Scale / team
- Cross-functional product delivery across nine healthcare programs
- Evidence
- 3 source notes · 3 explicit limits
$500K in new revenue supported and approximately $3M in client performance-based payouts across the broader program.
Nine programs. One reusable delivery spine.
Select a program context to see what stayed shared and what remained specific.
Context and stakes
Risk models were only one layer of the product. The harder problem was turning several healthcare programs into a repeatable operating system for data, model delivery, reporting, and care-team action.
A model that never reaches a workflow is not a product. A dashboard without a governed delivery path does not create durable adoption.
My role
I led data science and product work across risk modeling, reusable delivery patterns, program reporting, and care-manager workflows. The role required translating between model development, client priorities, operational adoption, and measurable program outcomes.
Product architecture
Shared data products and deployment patterns supported program-specific models rather than forcing every use case through one score. A composite Health Index provided a common orientation while each program kept its own population, intervention, and review logic.
The platform connected model outputs to dashboards, outreach priorities, and care-manager workflows, then fed operational feedback into later releases.
The decision that mattered
I treated delivery and adoption as part of the model system. Reusable pipelines shortened release cycles, but program-specific review and workflow design stayed explicit so scale did not erase local context.
What failed or was unreliable
A universal score was tempting but too blunt for nine different program goals. Reporting that did not match care-team work created friction even when the underlying model performed well. Data refresh and definition drift also needed product ownership, not one-time cleanup.
Validation and operations
Validation combined model quality with delivery checks, cohort review, workflow adoption, and program outcomes. Release patterns reduced repeated engineering work while leaving room for program-specific thresholds, interventions, and monitoring.
Outcome
The platform supported $500K in new revenue and approximately $3M in client performance-based payouts across the broader program. Reusable delivery patterns reduced model deployment cycles by approximately 50%. These are scoped career-record outcomes, not single-model claims.
What I would improve next
I would formalize a shared model-card and workflow-card release contract, add adoption telemetry by program, and make change-impact reviews part of every data or model release.
Source notes
What you can inspect—and what remains private.
Career record
Role, nine-program scale, revenue, P4P impact, and faster delivery are supported by the current career record.
Portfolio reconstruction
The product map and Health Index visual are authored here from approved facts without private data.
Private implementation
Client dashboards, datasets, model features, contracts, and operational rules are intentionally not published.
Limits
- Outcomes belong to the broader product and program context, not one model.
- The public visual is a reconstruction, not a private dashboard.
- No clinical effectiveness claim is made.
The product map is an authored reconstruction. No client data, private dashboard, model feature, clinical metric, contract term, or employer artifact is reproduced.
Illustrative product map
health_index:
inputs: [risk, utilization, quality]
programs: 9
delivery: reusable_pipeline
users: care_management
review: program_specific